IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2016. The put-call ratio across all filers is 269.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,913,000 | +9.5% | 201,207 | -6.3% | 0.00% | +50.0% |
| Q4 2017 | $3,574,000 | -31.7% | 214,669 | -16.8% | 0.00% | -50.0% |
| Q3 2017 | $5,235,000 | +36.4% | 257,868 | +8.1% | 0.00% | +33.3% |
| Q2 2017 | $3,839,000 | +28.6% | 238,473 | +1.0% | 0.00% | +50.0% |
| Q1 2017 | $2,986,000 | -8.1% | 236,010 | -3.8% | 0.00% | 0.0% |
| Q4 2016 | $3,249,000 | -43.2% | 245,242 | +1.5% | 0.00% | -50.0% |
| Q3 2016 | $5,724,000 | -18.4% | 241,521 | -0.8% | 0.00% | -20.0% |
| Q2 2016 | $7,015,000 | -9.2% | 243,418 | +0.9% | 0.01% | -16.7% |
| Q1 2016 | $7,726,000 | -28.4% | 241,285 | -4.4% | 0.01% | -25.0% |
| Q4 2015 | $10,793,000 | +18.3% | 252,401 | -2.6% | 0.01% | +14.3% |
| Q3 2015 | $9,127,000 | -27.4% | 259,205 | -5.3% | 0.01% | -22.2% |
| Q2 2015 | $12,568,000 | -5.1% | 273,693 | -3.1% | 0.01% | 0.0% |
| Q1 2015 | $13,241,000 | +46.5% | 282,508 | -1.0% | 0.01% | +50.0% |
| Q4 2014 | $9,037,000 | +24.4% | 285,246 | -6.9% | 0.01% | +20.0% |
| Q3 2014 | $7,262,000 | -21.9% | 306,289 | -1.2% | 0.01% | -16.7% |
| Q2 2014 | $9,294,000 | +10.3% | 309,913 | -2.8% | 0.01% | 0.0% |
| Q1 2014 | $8,427,000 | +3.5% | 318,957 | -1.5% | 0.01% | 0.0% |
| Q4 2013 | $8,140,000 | +14.5% | 323,797 | -6.6% | 0.01% | 0.0% |
| Q3 2013 | $7,111,000 | -12.9% | 346,693 | -15.2% | 0.01% | -14.3% |
| Q2 2013 | $8,161,000 | – | 409,074 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |